Home/Filings/4/0001062993-22-006836
4//SEC Filing

Zhang Junge 4

Accession 0001062993-22-006836

CIK 0001372299other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:03 PM ET

Size

11.0 KB

Accession

0001062993-22-006836

Insider Transaction Report

Form 4
Period: 2022-03-03
Zhang Junge
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-03$0.51/sh+39,000$19,89039,000 total
  • Exercise/Conversion

    Common Stock

    2022-03-03$1.83/sh+49,000$89,67088,000 total
  • Exercise/Conversion

    Option (Right to Buy)

    2022-03-03+39,00015,000 total
    Exercise: $0.51Exp: 2030-01-02Common Stock (39,000 underlying)
  • Exercise/Conversion

    Option (Right to Buy)

    2022-03-03+49,00077,000 total
    Exercise: $1.83Exp: 2031-01-01Common Stock (49,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    876,904
Footnotes (2)
  • [F1]The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.
  • [F2]The options, initially representing a right to purchase 126,000 shares, vest and become exercisable in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.

Issuer

Ocugen, Inc.

CIK 0001372299

Entity typeother

Related Parties

1
  • filerCIK 0001790205

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:03 PM ET
Size
11.0 KB